The authors showed increased GFAP blood-levels associated to older age, apolipoprotein epsilon4 status, and cognitive impairment, while decreased GFAP levels were associated with higher body mass index, diabetes, and tobacco use [29]. This evidence concerns the gene GFAP and Cognitive impairment.